רבלימיד 15 מ"ג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

LENALIDOMIDE 15 MG

Dostupno od:

NEOPHARM SCIENTIFIC LTD

ATC koda:

L04AX04

Farmaceutski oblik:

CAPSULES

Administracija rute:

PER OS

Proizveden od:

CELGENE EUROPE LTD, UK

Terapijska grupa:

LENALIDOMIDE

Terapijske indikacije:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Datum autorizacije:

2009-04-01